Stephen Delaney, who took the helm as CEO of Q1 Scientific in 2018 and advanced to Managing Director in 2022, has been a driving force behind Q1 Scientific’s remarkable success. Under his visionary leadership, Q1 Scientific has been propelled to new heights, earning accolades such as the prestigious ‘Contract Services Company of the Year’ at the Pharma Industry Awards in 2020 and ‘Business of the Year’ at the Waterford Chamber Business Awards in 2021.

In 2023, Stephen led the expansion of Q1 Scientific’s Waterford facility, transforming it into a state-of-the-art pharmaceutical stability storage hub spanning 30,000 square feet. At the same time, he oversaw the launch of a second 20,000 square feet stability storage facility in Belgium. This state-of-the-art cGMP facility, located in the Liège region, significantly elevated Q1 Scientific’s service to European customers by offering advanced temperature-controlled transport options and expanding stability storage capacity in mainland Europe.

Continuing his trailblazing efforts, Stephen led the opening of a third facility in Durham, North Carolina, USA, in 2024. This expansion significantly boosted Q1 Scientific’s capacity for environmentally controlled stability storage services, catering to the pharmaceutical, medical device, and life sciences industries in North America.

As Managing Director of Q1 Scientific, Stephen plays a pivotal role in the R&D supply chain for new medicinal products and devices, ensuring that Q1 Scientific’s temperature-controlled stability storage meets the rigorous demands of the world’s leading pharmaceutical and medical device companies.

Stephen holds a degree in Materials Technology and Engineering from the University of Limerick (2010) and a Master’s degree in Business Management from Smurfit Business School.

Cécile Jacoby joined Q1 Scientific as General Manager in 2023 to manage our 20,000 square feet facility in Belgium. With more than 25 years of experience in senior strategic and operations roles across pharmaceutical, vaccine, healthcare and cell therapy companies, Cécile has a proven track record in developing, driving and managing business operations. After working at Director level in GSK for over 10 years, Cécile became a Senior Executive Consultant delivering several worldwide assignments to pharmaceutical, R&D and biotechnology companies. Cécile also took over the general management of a Belgian Biotech group’s subsidiary and an industrial group’s holding company.

Amy Trinchard brings over 23 years of experience in the biotech industry to her role as Director of US Operations at Q1 Scientific in Durham. With a strong background in project and sample management, Amy oversees the daily operations of our state-of-the-art stability storage services in the US, ensuring the highest standards of quality and efficiency.

In her current role, Amy leads a dedicated team, driving innovation and excellence in stability storage solutions. She is responsible for strategic planning, operational management, and client relations, ensuring that Q1 Scientific continues to safeguard critical breakthroughs and life-changing innovations.

Before joining Q1 Scientific, Amy spent 7 years at Cambrex, most recently as Director of Project Management in Early Stage Development and Testing, where she led teams in Durham, NC, and Longmont, CO. She also has 17 years of experience at Monsanto, where she led Project and Sample Management teams and developed software systems for inventory management.